Callan Capital’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-800
| Closed | -$9.35K | – | 303 |
|
|
2023
Q4 | $9.35K | Hold |
800
| – | – | ﹤0.01% | 234 |
|
|
2023
Q3 | $12K | Hold |
800
| – | – | ﹤0.01% | 204 |
|
|
2023
Q2 | $16.6K | Hold |
800
| – | – | ﹤0.01% | 183 |
|
|
2023
Q1 | $7.05K | Hold |
800
| – | – | ﹤0.01% | 183 |
|
|
2022
Q4 | $8.55K | Hold |
800
| – | – | ﹤0.01% | 186 |
|
|
2022
Q3 | $11K | Hold |
800
| – | – | ﹤0.01% | 129 |
|
|
2022
Q2 | $28K | Buy |
+800
| New | +$28K | ﹤0.01% | 111 |
|